(9S,10S)-9,10-dihydroxyoctadecanoate
|
Basic information |
| Metabolite name | (9S,10S)-9,10-dihydroxyoctadecanoate |
 | HMDB0059633 |
 |
C15988 |
 |
12235230 |
| Synonyms | NA |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | (9S,10S)-9,10-dihydroxyoctadecanoate |
| HMDB0059633 |
|
C15988 |
|
12235230 |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between (9S,10S)-9,10-dihydroxyoctadecanoate and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M949 | Type1 | ovariectomy group vs. control group | Serum | ICR mouse | Down |
| Study M949 | Type2 | ovariectomy + fluoxetine group vs. ovariectomy group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + low dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + middle dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + high dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Up |